Infors USA Inc.

Annapolis Junction, MD

UEI
HF7MNLWTNBE1
CAGE
72Y23
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
9070 Junction Dr d, Annapolis Junction, MD 20701, USA
Website
infors-ht.com
Founded
1965
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $401,995
FY2025 $167,324
FY2024 $711,738
FY2023 $566,880

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $318,170
2 Department of Agriculture $83,825

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
Roberts Oxygen Co Inc. NIAID VRC FY26-27 OPERATIONAL TASK ORDER Service Maintenance Agreement for Shaking Incubators. 75N91025F00014 $112,500
IT1 Source LLC NIAID VRC OPERATIONAL TASK ORDER Capital Equipment 75N91024F00014 $277,050

Similar vendors

About the company

Infors USA Inc., a for-profit manufacturer of bioreactors, incubation shakers, and fermentation monitoring equipment based in Annapolis Junction, Maryland, operates as a prime contractor on federal purchase orders, selling specialized laboratory instruments to research agencies across the Department of Health and Human Services and the Department of Agriculture. The vendor competes predominantly full-and-open, with no meaningful use of small-business set-asides — of 117 total awards in the source data, approximately 30% carry total small business set-aside designations, while the majority are unrestricted procurements or sole-source awards.

Infors USA's customer concentration is heavily skewed toward biomedical research. The top five funding agencies account for 68% of awards by count and 67% by combined potential value. The National Institute of Allergy and Infectious Diseases dominates this footprint with 36 awards valued at $2.1 million combined, driven by recurring procurement of Minitron and Multitron incubation shakers and CO2-controlled variants to support vaccine development and infectious disease research. The National Institutes of Health National Institute of Environmental Health Sciences follows with 10 awards ($469 thousand), followed by the National Heart Lung and Blood Institute (11 awards, $264 thousand), the National Cancer Institute (15 awards, $214 thousand), and the National Institute of Child Health and Human Development (7 awards, $202 thousand). The Food and Drug Administration and the Department of Agriculture Agricultural Research Service round out the active set. Representative prime awards include a $199,930 purchase order from FDA (August 2026) for an Infors HT Multitron Triple-Stack Shaker System; a $166,618.80 Department of Agriculture Agricultural Research Service contract (September 2023) for a microbial chemostat; a $169,060 purchase order from the National Institute of Environmental Health Sciences (September 2023) for Infors Multitron laboratory incubation shakers; and a $193,047 purchase order from NIAID (August 2024) for HT Multitron and Minitron incubator shakers. All prime awards are firm fixed-price purchase orders; the vendor does not hold parent contract vehicles such as GWACs or IDIQs.

Award volume has remained relatively stable at 10–11 awards annually through 2024, declining to 5 awards in 2025 and 4 in 2026 year-to-date. Combined potential value across all 117 awards totals $4.9 million, with obligated dollars at $5.3 million (108% of potential value). Only two awards face ultimate completion within the next twenty-four months, with combined potential value of $296 thousand — minimal recompete exposure. The vendor holds 115 prime awards (98%) and 2 sub-awards (2%). Under the subcontractor role, Infors USA supplies shaking incubator maintenance services and capital equipment to Roberts Oxygen Co Inc. and IT1 Source LLC, both under NIAID Vaccine Research Center operational task orders. Procurement is concentrated in NAICS 334516 (Analytical Laboratory Instrument Manufacturing; 106 of 117 awards) and PSC Laboratory Equipment and Supplies (92 of 117 awards). The source data spans from June 2014 to August 2026, with federal agency relationships established across 25 distinct customer agencies, predominantly within NIH institutes and HHS operating divisions.

Quick answers

Is Infors USA Inc. registered in SAM.gov?

Yes. Infors USA Inc.'s SAM.gov registration is active through June 15, 2027.

How much has Infors USA Inc. received in federal contracts?

Federal contracts obligated $167,324 to Infors USA Inc. in fiscal year 2025 and $1,847,937 in fiscal years 2023 through 2027.

What is Infors USA Inc.'s most recent federal award?

Infors USA Inc.'s most recent federal contract award is Infors HT multitron triple-stack shaker system (75F40126P00230), from Food and Drug Administration, on August 19, 2026.

On GovTribe

See Infors USA Inc.'s full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors